Johnson & Johnson seeks COVID-19 vaccine approval in Japan

Over the current book year the company from New Brunswick could achieve a revenue around 91.47 billion USD (consensus estimates). This is hugely more than 2020's revenue of 82.58 billion USD.

Historical revenues and results Johnson & Johnson plus estimates 2020

The analysts expect for 2021 a net profit of 25.49 billion USD. Most of the analysts anticipate on a profit per share of 9.52 USD. Based on this the price/earnings-ratio is 17.73.

Analysts expect a dividend of 4.19 USD per share. Johnson & Johnson 's dividend yield thus equals 2.48 percent. The average dividend yield of the health care companies is a poor 1.46 percent.

Based on the current number of shares Johnson & Johnson 's market capitalization equals 444.39 billion USD. The Johnson & Johnson stock was the past 12 months quite unstable. Since last May the stock is 18 percent higher. This year the stock price moved between 134 and 174 dollar.

Historical stock prices Johnson & Johnson

At 16.57 the stock trades 1.18 percent higher at 168.81 USD.

Analist.nl Nieuwsdienst: +31 084-0032-842
nieuws@analist.nl

Copyright analist.nl B.V.
All rights reserved. Any redistribution, duplication or archiving prohibited. Analist.nl doesn't warrant the accuracy of any News Content provided and shall not be liable for any errors, inaccuracies or for any actions taken in reliance thereon.